Reported Breast, Colorectal Cancer Screening Higher in 2023 Than 2019
By Elana Gotkine HealthDay Reporter
MONDAY, March 17, 2025 -- In 2023, reported breast and colorectal cancer screening rebounded from pandemic-related declines, and rates were higher than in 2019, according to a research letter published online March 5 in the Journal of the American Medical Association.
Jessica Star, M.P.H., from the American Cancer Society in Atlanta, and colleagues obtained data from the National Health Interview Survey to estimate postpandemic cancer screening rates in 2023 relative to previously documented declines through 2021.
In 2023, 6,829, 8,888, and 13,144 individuals were eligible for breast, cervical, and colorectal cancer screening, respectively. The researchers found that the reported past-year breast cancer screening and colorectal screening increased by 7 and 12 percent, respectively, between 2019 and 2023. Rebounds between 2021 and 2023 in breast cancer screening and colonoscopy screening underlay these increases (adjusted prevalence ratios, 1.14 and 1.13, respectively), as did a sustained increase in stool testing (6.6 percent in 2019 and 10.1 percent in 2021 and 2023). In 2023, reported cervical cancer screening remained below 2019 estimates (adjusted prevalence ratio, 0.86), and was unchanged from 2021.
"To prevent further shifts toward later-stage diagnoses, efforts must address declines in cervical cancer screening and disparities by socioeconomic status in all three screening types," the authors write. "Health systems and health care professionals could play a major role by improving screening communications and providing patient navigators to help address structural and cost barriers."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted March 2025
Further Support and Information on COVID-19
Read this next
CT Colonography Cost-Effective, Clinically Effective for CRC Screening
MONDAY, June 16, 2025 -- Computed tomography colonography (CTC) is cost-effective and clinically effective for colorectal cancer (CRC) screening, according to a study published...
Blood-Based Screening Has Acceptable Accuracy for Colorectal Cancer Detection
THURSDAY, June 12, 2025 -- A blood-based test has acceptable accuracy for colorectal cancer detection but not for advanced precancerous lesions in an average-risk colorectal...
Screening Colonoscopy IDs Similar Rates of CRC for 45 to 49 as 50 to 54 Years
TUESDAY, June 10, 2025 -- Rates of colorectal cancer detection through colonoscopy screening are similar for adults aged 45 to 49 years and 50 to 54 years, according to a research...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.